STU3 Candidate

This page is part of the FHIR Specification (v1.8.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

4.3.1.408 Value Set http://hl7.org/fhir/ValueSet/condition-stage

This is a value set defined at http://www.hl7.org/Special/committees/patientcare/ .

Summary

Defining URL:http://hl7.org/fhir/ValueSet/condition-stage
Name:Condition Stage
Definition:Example value set for stages of cancer and other conditions
Committee:Patient Care Work Group
OID:2.16.840.1.113883.4.642.2.408 (for OID based terminology systems)
Copyright:This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement.
Source ResourceXML / JSON

This value set is used in the following places:

4.3.1.408.1 Content Logical Definition

This value set includes codes from the following code systems:

 

4.3.1.408.2 Expansion

This expansion generated 06 Dec 2016

This value set contains 1038 concepts

All codes from system http://snomed.info/sct

CodeDisplayDefinition
786005Clinical stage I B (finding)
1523005Clinical stage IV B
2640006Clinical stage IV (finding)
2786004Epithelial ovarian tumor, FIGO stage III
5701003Lymphoma stage IIe
5856006N3 category (finding)
6123003pT4 category (finding)
6534007Epithelial ovarian tumor, FIGO stage IIA
13104003Clinical stage I
14410001T3 category (finding)
14926007pM1 category (finding)
14927003FIGO VC stage II
15076001pN2 category (finding)
15540006International Federation of Gynecology and Obstetrics cervical cancer stage I (finding)
15542003Clinical stage I C (finding)
17076002pMX category (finding)
17691001Clinical stage I S
17816005Clinical stage II B
19408000pM0 category (finding)
21917009pN0 category (finding)
22079002N4 category (finding)
22364004FIGO VC stage III
23351008T1 category (finding)
25654007International Federation of Gynecology and Obstetrics cervical cancer stage Ib (finding)
27167007MX category (finding)
30382004FIGO EC stage II
30440004Lymphoma stage I
30893008M0 category (finding)
31747005Modified Dukes stage B1
33177002Clinical stage IV C
33907000Clinical stage III E
34537009FIGO EC stage IV
35440002Clinical stage I D
36018006Epithelial ovarian tumour, FIGO stage IA
37415008Epithelial ovarian tumor, FIGO stage IC
39617003Clinical stage II C
39880006pT0 category (finding)
43189003pTX category (finding)
44255004Lymphoma stage IIIe
44401000Tis category (finding)
45552005pN1 category (finding)
46059003N2 category (finding)
46333007Clinical stage I A (finding)
46756001FIGO EC stage I A
48105005Clinical stage III C (finding)
49182004pN3 category (finding)
49219005International Federation of Gynecology and Obstetrics cervical cancer stage Ia (finding)
50237009FIGO EC stage I
50283003Clinical stage III
52708004FIGO CC stage III
52774001Clinical stage II A
52865009Clinical stage IV D
53173007Modified Dukes stage B2
53623008N1 category (finding)
53786006pT1 category (finding)
54452005pNX category (finding)
54498006Modified Dukes stage C1
55336000Clinical stage III D (finding)
55440008M1 category (finding)
56380009Clinical stage I E
56587006FIGO VC stage I
56769006Modified Dukes stage A
56944001Lymphoma stage III
57306005Modified Dukes stage C2
57605004Modified Dukes stage D
58790005T0 category (finding)
60275007FIGO EC stage I B
60333009Clinical stage II
62455006N0 category (finding)
64062008Clinical stage III B (finding)
64202001Clinical stage IV E
64574000Epithelial ovarian tumor, FIGO stage IIB
64737002Epithelial ovarian tumor, FIGO stage IB
64877001Clinical stage III S
65235001Epithelial ovarian tumor, FIGO stage I
65306007FIGO VM stage II
65536004FIGO VM stage III
65565005T4 category (finding)
66445009Lymphoma stage IV
67101007TX category (finding)
67673008T2 category (finding)
68240008FIGO CC stage II
69605008Clinical stage II E
70046009FIGO VM stage I
70664003Clinical stage IV S
71725004Clinical stage IV A
72780008FIGO VC stage IV
73055006FIGO VM stage V
73082003Clinical stage III A (finding)
73511008Epithelial ovarian tumor, FIGO stage IV
74053007Lymphoma stage IIIs
75339006Lymphoma stage III 2
76422004Lymphoma stage II
78199001Epithelial ovarian tumor, FIGO stage IIC
78607009Epithelial ovarian tumor, FIGO stage II
79420006NX category (finding)
80588003FIGO VM stage IV
80663004pN4 category (finding)
80898003pT2 category (finding)
80975007FIGO EC stage III
81822003FIGO CC stage IV
84633001Lymphoma stage IIIse
84921008pTis category (finding)
87977001FIGO CC stage Ib occ
89487002Lymphoma stage Ie
90321006Clinical stage II S
90402004pT3 category (finding)
112240001Clinical stage II D
112241002Lymphoma stage III 1
258297005Metastasis stage M2
258298000Metastasis stage M3
258299008Metastasis stage M4
261646003Tumour stage T1a
261647007Tumor stage T1a1
261648002Tumour stage T1a2
261649005Tumor stage T1b
261650005Tumour stage T1c
261651009Tumor stage T2a
261652002Tumour stage T2b
261653007Tumor stage T2c
261654001Tumor stage T3a
261655000Tumour stage T3b
261656004Tumor stage T3bi
261657008Tumour stage T3bii
261658003Tumor stage T3c
261659006Tumour stage T4a
261660001Tumor stage T4b
261661002Tumour stage T4c
261662009Tumor stage T4d
261927002Metastasis stage M1a
261928007Metastasis stage M1b
261929004Metastasis stage M1c
261967001Node stage N2a
261968006Node stage N2b
261969003Node stage N2c
277672002Node stage N1a
277674001Node stage N1b
277744001Metastasis stage pM1
277772008Node stage N1bi
277776006Node stage N1bii
277777002Node stage N1biii
277778007Node stage N1biv
313108002Tumour stage T1mic
313110000Tumour stage T1b1
313111001Tumor stage T1b2
313145008Tumour stage Tis pu
313146009Tumor stage Tis pd
369793000Tis (--): Carcinoma in situ (endometrium / uterine cervix)
369794006T1 (I): Cervical carcinoma confined to uterus
369795007T1a (IA): Invasive carcinoma of uterine cervix diagnosed by microscopy only
369796008T1a1 (IA1): Tumor of uterine cervix with stromal invasion < 3.0 mm in depth and horizontal spread < 7.0 mm
369797004T1a2 (IA2): Tumour of uterine cervix with stromal invasion > 3.0 mm but < 5.0 mm in depth and horizontal spread < 7.0 mm
369798009T1b (IB): Tumor of uterine cervix with clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2
369799001T1b1 (IB1): Tumor of uterine cervix, clinically visible lesion < 4.0 mm in greatest dimension
369800002T1b2 (IB2): Tumor of uterine cervix, clinically visible lesion > 4.0 mm in greatest dimension
369801003T2 (II): Tumor of uterine cervix invades beyond the uterus but not to pelvic wall or to lower third of vagina
369802005T2a (IIA): Tumor of uterine cervix, T2 without parametrial invasion
369803000T2b (IIB): Tumor of uterine cervix, T2 with parametrial invasion
369804006T3 (III): Tumour of uterine cervix extends to the pelvic wall and/or involves the lower third of the vagina and/or causes hydronephrosis or nonfunctioning kidney
369805007T3a (IIIA): Tumor of uterine cervix involves lower third of vagina, but not pelvic wall
369806008T4 (IVA): Tumor of uterine cervix/vagina invades mucosa of bladder or rectum and/or extends beyond true pelvis
369807004T1 (I): Endometrial tumor confined to corpus uteri
369808009T1a (IA): Tumor limited to endometrium
369809001T1b (IB): Endometrial tumor invades up to or less than one half of the endometrium
369810006T1c (IC): Endometrial tumor invades to more than one half of the endometrium
369811005T2 (II): Endometrial tumour invades cervix, but does not extend beyond uterus
369812003T2a (IIA): Endometrial tumor with endocervical glandular involvement (finding)
369813008T2b (IIB): Endometrial tumor with cervical stromal invasion
369814002T3 (III): Endometrial tumor with local and/or regional spread as specified in T3a, b, N1 and FIGO IIIA, B, and C below or adnexa (direct extension or metastasis) and/or cancer cells in ascites or peritoneal washings
369815001T3b (IIIB): Endometrial tumor with vaginal involvement (direct extension or metastasis)
369816000T4 (IVA): Endometrial tumor invades bladder mucosa and/or bowel mucosa
369817009T1 (I): Tumor confined to vagina
369818004T2 (II): Vaginal tumour invades paravaginal tissues but not to pelvic wall
369819007T3 (III): Vaginal tumor extends to pelvic wall
369820001T1 (I): Tumor limited to fallopian tube(s)
369821002T1a (IA): Tumor limited to one fallopian tube without penetrating the serosal surface, no ascites
369822009T1b (IB): Tumor limited to both tubes without penetrating the serosal surface: no ascites
369823004T1c (IC): Tumor limited to one or both tube(s) with extension into or through the tubal serosa; or with malignant cells in ascites or peritoneal washings: FALLOPIAN TUBE: Salpingectomy
369824005T2 (II): Fallopian tube tumor involves one or both tube(s) with pelvic extension
369825006T2a (IIA): Fallopian tube tumour with extension and/or metastasis to the uterus and/or ovaries
369826007T2b (IIB): Fallopian tube/ovarian tumor with extension to other pelvic structures
369827003T2c (IIC): Fallopian tube/ovarian tumor with pelvic extension (T2a or b) with malignant cells in ascites or peritoneal washings
369828008T3 and/or N1 (III): Fallopian tube tumor involves one or both tube(s) with peritoneal implants outside the pelvis and/or regional lymph node metastasis
369829000T3a (IIIA): Fallopian tube/ovarian tumor with microscopic peritoneal metastasis beyond pelvis
369830005T3b (IIIB): Fallopian tube/ovarian tumor with macroscopic peritoneal metastasis beyond pelvis < 2 cm in greatest dimension
369831009T3c (IIIC): Fallopian tube/ovarian tumor with peritoneal metastasis beyond pelvis > 2 cm in greatest dimension and/or regional lymph node metastasis
369832002T1: Clinically inapparent prostate tumour not palpable or visible by imaging
369833007T1a: Prostate tumor incidental histologic finding in 5% or less of tissue resected (finding)
369834001T1b: Prostate tumor incidental histologic finding in > 5% of tissue resected
369835000T1c: Tumor identified by needle biopsy because of elevated PSA: PROSTATE: Biopsy/TURP: PROSTATE: Resection
369836004T2a: Prostate tumor involves one lobe
369837008T3: Prostate tumor extends through the prostatic capsule
369838003T3a: Prostate tumor with extracapsular extension (unilateral or bilateral)
369839006T3b: Prostate tumour invades the seminal vesicle(s)
369840008T2: Aerodigestive tract tumor causing bone erosion or destruction, except for the posterior antral wall, including extension into hard palate and/or middle nasal meatus
369841007T1: Aerodigestive tract tumor < 2 cm in greatest dimension
369842000T1: Aerodigestive tract tumor confined to ethmoid with or without bone erosion
369843005T1: Aerodigestive tract tumor confined to nasopharynx
369844004T1: Tumor limited to one subsite of hypo-pharynx and < 2 cm in greatest dimension
369845003T1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility
369846002T1: Tumour limited to subglottis
369847006T1: Tumor limited to the antral mucosa with no erosion or destruction of bone
369848001T1: Tumor limited to vocal cord(s) (may involve anterior or posterior commissure) with normal mobility
369849009T1a: Tumor limited to one vocal cord
369850009T1b: Tumor involves both vocal cords
369851008T2: Aerodigestive tract tumour > 2 cm but < 4 cm in greatest dimension
369852001T2: Aerodigestive tract tumor > 2 cm but < 4 cm in greatest dimension without extraparenchymal extension
369853006T2: Aerodigestive tract tumor extends into nasal cavity
369854000T2: Aerodigestive tract tumor extends to soft tissue of oropharynx and/or nasal fossa
369855004T2: Aerodigestive tract tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility
369856003T2: Aerodigestive tract tumor extends to vocal cord(s) with normal or impaired mobility
369857007T2: Aerodigestive tract tumor invades more than one subsite of hypopharynx or an adjacent site, or measures > 2 cm but < 4 cm in greatest dimension, without fixation of hemilarynx
369858002T2: Aerodigestive tract tumor invades mucosa of >1 adjacent subsite of supraglottis/glottis/region outside supraglottis, (mucosa of base of tongue/vallecula/medial wall of piriform sinus) without fixation of larynx
369859005T2a: Aerodigestive tract tumor without parapharyngeal extension
369860000T2b: Aerodigestive tract tumor with parapharyngeal extension
369861001T3: Aerodigestive tract tumor > 4 cm in greatest dimension
369862008T3: Aerodigestive tract tumor extends to anterior orbit and/or maxillary sinus
369863003T3: Aerodigestive tract tumor having extraparenchymal extension without seventh nerve involvement, and/or > 4 cm but < 6 cm in greatest dimension
369864009T3: Aerodigestive tract tumor invades any of the following: bone of posterior wall of maxillary sinus, subcutaneous tissues, skin of cheek, floor or medial wall of orbit, infratemporal fossa, pterygoid plates, ethmoid sinuses
369865005T3: Aerodigestive tumour invades bony structures and/or paranasal sinuses
369866006T3: Aerodigestive tract tumor limited to larynx with vocal cord fixation
369867002T3: Aerodigestive tract tumor limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, pre-epiglottic tissues, deep base of tongue
369868007T3: Aerodigestive tract tumor measures > 4 cm in greatest dimension, or with fixation of hemilarynx
369869004T4: Lip: Tumor invades adjacent structures (cortical bone, inferior alveolar nerve, floor of mouth, skin of face)
369870003T4: Oral Cavity: Tumor invades adjacent structures (cortical bone, deep (extrinsic) muscle of tongue, maxillary sinus, skin)
369871004T4: Aerodigestive tract tumor invades adjacent structures (pterygoid muscles, mandible, hard palate, deep muscle of tongue, larynx)
369872006T4: Aerodigestive tract tumor invades adjacent structures (thyroid/cricoid cartilage, carotid artery, soft tissues of neck, prevertebral fascia/muscles, thyroid and/or esophagus) (finding)
369873001T4: Aerodigestive tumor invades base of skull, seventh nerve, and/or exceeds 6 cm in greatest dimension
369874007T4: Aerodigestive tract tumor invades orbital contents beyond the floor or medial wall including apex and/or any of the following: cribriform plate, base of skull, nasopharynx, sphenoid sinus, frontal sinus
369875008T4: Tumor invades through cricoid or thyroid cartilage and/or extends into other tissues beyond the larynx (trachea, soft tissues of neck, thyroid, esophagus)
369876009T4: Tumor invades through thyroid cartilage and/or extends to other tissues beyond the larynx (trachea, soft tissues of neck, pharynx)
369877000T4: Tumor invades through thyroid cartilage, and/or extends into soft tissues of the neck, thyroid, and/or esophagus
369878005T4: Aerodigestive tract tumor with intracranial extension and/or involvement of cranial nerves, infratemporal fossa, hypopharynx or orbit
369879002T4: Aerodigestive tract tumor with intracranial extension, orbital extension including apex, involving sphenoid and/or frontal sinus and/or skin of nose
369880004T1: Lung tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (finding)
369881000T2:Lung tumour with any of these features:>3cm in greatest dimension, involves main bronchus >2cm distal to carina; invades visceral pleura; assoc with atelectasis/obstructive pneumonitis extends to hilar region, does not involve entire lung
369882007T3: Lung tumor of any size associated atelectasis or obstructive pneumonitis of the entire lung
369883002T3: Lung tumor of any size in the main bronchus < 2 cm distal to the carina but without involvement of the carina
369884008T3: Lung tumour of any size that directly invades any of the following: chest wall (including superior sulcus tumors); diaphragm; mediastinal pleura; parietal pericardium
369885009T4: Lung tumor of any size that invades any of the following: mediastinum; heart; great vessels; trachea; esophagus; vertebral body; carina
369886005T4: Lung tumor of any size with a malignant pleural effusion
369887001T4: Lung tumor of any size with separate tumor nodule(s) in same lobe
369888006T1: Kidney tumor < 7.0 cm in greatest dimension limited to the kidney
369889003T2: Renal tumor > 7.0 cm in greatest dimension limited to the kidney
369890007T3: Renal tumour extends into major veins or invades the adrenal gland or perinephric tissues but not beyond Gerota's fascia
369891006T3a: Renal tumor invades the adrenal gland or perinephric tissues but not beyond Gerota's fascia
369892004T3b: Renal tumor grossly extends into the renal vein(s) or vena cava below the diaphragm
369893009T3c: Renal tumor grossly extends into the vena cava above the diaphragm
369894003T4: Renal tumor invades beyond Gerota's fascia
369895002T1: Breast tumor <= 2 cm in greatest dimension
369896001T1mic: Microinvasion <= 0.1 cm in greatest dimension: BREAST: Complete excision less than total mastectomy, total mastectomy, modified radical mastectomy, radical mastectomy
369897005T1a: Breast tumour >0.1 cm but <= 0.5 cm in greatest dimension
369898000T1b: Breast tumor >0.5 cm but <= 1 cm in greatest dimension
369899008T1c: >1 cm but <= 2 cm in greatest dimension: BREAST: Complete excision less than total mastectomy, total mastectomy, modified radical mastectomy, radical mastectomy
369900003T2: Breast tumor > 2 cm but <= 5 cm in greatest dimension
369901004T3: Breast tumor >5 cm in greatest dimension
369902006T4: Breast tumor of any size with direct extension to chest wall or skin
369903001T4a: Breast tumour with extension to chest wall
369904007T4b: Edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast
369905008T4c: Breast tumor, both T4a and T4b
369906009T4d: Inflammatory carcinoma (breast)
369907000Tis: Carcinoma in situ, breast: Intraductal carcinoma, lobular carcinoma in situ, or Paget's disease of the nipple with no tumor
369909002T1: Tumour invades lamina propria or submucosa
369910007T1a: Esophagus/stomach tumor invades lamina propria
369911006T1b: Esophagus/stomach tumor invades submucosa
369912004T2: Tumor invades muscularis propria
369913009T3: Esophageal tumor invades adventitia
369914003T4: Tumor directly invades adjacent structures
369915002T2: Stomach tumor invades muscularis propria or subserosa
369916001T2a: Stomach tumour invades muscularis propria
369917005T2b: Stomach tumor invades subserosa
369918000T3: Stomach tumor penetrates serosa without invasion of adjacent structures
369919008T4a: Colon/rectum tumor directly invades other organs or structures
369920002T1: Tumor invades submucosa (colon/rectum) (finding)
369921003T3: Colon/rectum tumor invades through the muscularis propria into the subserosa or the nonperitonealized pericolic or perirectal soft tissues
369922005T4b: Colon/rectum tumor penetrates the visceral peritoneum
369923000Tis (0): Carcinoma in situ (vagina) (finding)
369924006Tis (0): Carcinoma in situ (limited to fallopian tube mucosa)
369925007Tis: Epithelium only (carcinoma in situ, no invasion)
369926008T1: Tumor limited to ampulla of Vater or sphincter of Oddi
369927004T2: Ampulla tumor invades duodenal wall
369928009T3: Ampulla tumor invades 2 cm or less into pancreas
369929001T4: Ampulla tumour invades >2 cm into pancreas and/or into other adjacent organs
369930006T1: Tumor limited to pancreas and < 2 cm in greatest dimension
369931005T2: Tumor limited to pancreas and > 2 cm in greatest dimension
369932003T3: Pancreatic tumor extends directly to any of the following: duodenum; bile duct; peripancreatic tissues
369933008T4: Pancreas tumor extends directly to any of the following: stomach; spleen; colon; adjacent large vessels
369934002Tis: Carcinoma in situ ("flat tumor" of urinary bladder) (finding)
369935001T1: Urinary tract tumor invades subepithelial connective tissue
369936000T2: Urinary bladder tumour invades muscle
369937009T2: Renal pelvis/ureter tumor invades the muscularis
369938004T2a: Urinary bladder tumor invades superficial muscle (inner half)
369939007T2b: Urinary bladder tumor invades deep muscle (outer half)
369940009T3: Ureteral tumor invades beyond muscularis into periureteric fat
369941008T3: Renal pelvis tumor invades beyond muscularis peripelvic fat or the renal parenchyma
369942001T3: Urinary bladder tumor invades perivesical tissue
369943006T3a: Bladder tumour invades perivesical tissue microscopically
369944000T3b: Bladder tumor invades perivesical tissue macroscopically (extravesicular mass)
369945004T4: Urinary bladder tumor invades any of the following: prostate, uterus, vagina, pelvic wall abdominal wall
369946003T4: Renal pelvis/ureter tumor invades adjacent organs, or through the kidney into the perinephric fat
369947007T4a: Bladder tumor invades prostate or uterus or vagina
369948002T4b: Bladder tumor invades pelvic wall or abdominal wall
369949005Ta: Noninvasive papillary carcinoma (urinary tract)
369950005Tis: Intratubular germ cell neoplasia (carcinoma in situ, testis) (finding)
369951009T1: Testicular tumor limited to the testis and epididymis without vascular/lymphatic invasion (tumor may invade tunica albuginea but not tunica vaginalis)
369952002T2: Testicular tumor limited to the testis and epididymis with vascular/lymphatic invasion or tumor extending through tunica albuginea with involvement of tunica vaginalis
369953007T3: Testicular tumor invades spermatic cord with or without vascular/lymphatic invasion
369954001T4: Testicular tumor invades scrotum with or without vascular/lymphatic invasion
369955000T1 (I): Trophoblastic disease confined to uterus
369956004T1 (IA): Trophoblastic disease confined to uterus with no risk factors
369957008T1 (IB): Trophoblastic disease confined to uterus with one risk factor (finding)
369958003T1 (IC): Trophoblastic disease confined to uterus with two risk factors
369959006T2 (II): Trophoblast: GTT extends outside of the uterus but is limited to the genital structures (adnexa, vagina, broad ligament)
369960001T2 (IIA): Trophoblast: GTT involving genital structure without risk factors
369961002T2 (IIB): Trophoblast: GTT extends outside of the uterus but limited to genital structures with one risk factor
369962009T2 (IIC): Trophoblast: GTT extends outside of the uterus but limited to genital structures with two risk factors
369963004T1: Tumor limited to ipsilateral parietal and/or visceral pleura
369964005T2: Pleural tumour invades any of the following: ipsilateral lung, endothoracic fascia, diaphragm, or pericardium
369965006T3: Pleural tumor invades any of the following: ipsilateral chest wall muscle, ribs, or media-stinal organs or tissues
369966007T4: Pleural tumor directly extends to any of the following: contralateral pleura, contralateral lung, peritoneum, intra-abdominal organs, cervical tissues
369967003T1: Tumor size < 1 cm, limited to thyroid
369968008T2: Tumor > 1 cm but < 4 cm, limited to thyroid
369969000T3: Thyroid tumor > 4 cm, limited to thyroid
369970004T4: Thyroid tumor of any size extending beyond the thyroid capsule
369971000T1a (IA): Tumour limited to one ovary, capsule intact, no tumour on ovarian surface
369972007T1b (IB): Tumor limited to both ovaries: capsule intact, no tumor on ovarian surface
369973002T1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings: OVARY: Resection
369974008T2: Ovarian tumor involves one or both ovaries with pelvic extension
369975009T2a (IIA): Ovarian tumor with extension and/or implants on uterus and/or tube(s)
369976005T3 and/or N1 (III): Ovarian tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis
369977001T3b (IIIB): Tumor of uterine cervix extends to pelvic wall and/or causes hydronephrosis or nonfunctioning kidney
369978006T2: Tumour confined within the prostate
369979003T1: Aerodigestive tract tumor < 2 cm in greatest dimension without extraparenchymal extension
369980000Tis: Tumor invades lamina propria (gastrointestinal tumor)
369981001Tis: Tumor invades muscularis mucosae (colon/rectum)
369982008T1: Solitary liver tumor < 2 cm; no vascular invasion
369983003N1: Metastasis to movable ipsilateral axillary lymph node(s)
369984009N1a: Only micrometastasis, none > 0.2 cm in greatest dimension
369985005N1b: Metastasis to lymph node(s), any > 0.2 cm in greatest dimension (finding)
369986006N1bi: Metastasis in 1 to 3 lymph nodes, any > 0.2 cm and all < 2 cm in greatest dimension
369987002N1bii: Metastasis in 4 or more lymph nodes, any > 0.2 cm and all < 2 cm in greatest dimension
369988007N1biii: Extension of tumor beyond the capsule of a lymph node metastasis, < 2 cm in greatest dimension
369989004N1biv: Metastasis to a lymph node > 2 cm in greatest dimension
369990008N2: Metastasis to ipsilateral axillary lymph node(s) fixed to one another or to other structures (finding)
369991007N3: Metastasis to ipsilateral internal mammary lymph node(s)
369992000N1: Metastasis in 1-3 lymph nodes
369993005N2: Metastasis in 4 or more lymph nodes
369994004N1a: 1-3 nodes involved
369995003N1b: 4-7 nodes involved
369996002N1c: >7 nodes involved
369997006N1: Metastasis in 1-6 perigastric lymph nodes (finding)
369998001N2: Metastasis in 7-15 perigastric lymph nodes
369999009N3: Metastasis in >15 perigastric lymph nodes
370000006N1: Metastasis in a single lymph node, < 2 cm in greatest dimension
370001005N1: Metastasis in a single lymph node, <= 2 cm in greatest dimension
370002003N2: Metastasis in a single lymph node, > 2 cm but <= 5 cm in greatest dimension, or multiple lymph nodes, none > 5 cm in greatest dimension
370003008N3: Metastasis in a lymph node > 5 cm in greatest dimension
370004002N1: Metastasis in a single ipsilateral lymph node, < 3 cm in greatest dimension (finding)
370005001N1: Unilateral metastasis in lymph node(s) > 6 cm in greatest dimension, above supraclavicular fossa
370006000N2: Metastasis in a single ipsilat lymph node >3cm but <6cm in greatest dimension; or in multiple ipsilat lymph nodes, none >6cm in greatest dimension; or in bilat or contralat lymph nodes, none >6cm in greatest dimension
370007009N2: Bilateral metastasis in lymph node(s) > 6 cm in greatest dimension, above supraclavicular fossa
370008004N2a: Metastasis in a single ipsilateral lymph node, > 3 cm but < 6 cm in greatest dimension
370009007N2b: Metastasis in multiple ipsilateral lymph nodes, none > 6 cm in greatest dimension
370010002N2c: Metastasis in bilateral or contralateral lymph nodes, none > 6 cm in greatest dimension
370011003N3: Metastasis in lymph node(s) (finding)
370012005N3a: > 6 cm in dimension
370013000N3b: extension to supraclavicular fossa
370014006N3: Metastasis in a lymph node > 6 cm in greatest dimension
370015007N1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumor
370016008N2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s)
370017004N3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene or supraclavicular lymph node(s) (finding)
370018009N1: Metastasis in a single lymph node
370019001N2: Metastasis in more than one regional lymph node
370020007N1: Metastasis with a lymph node mass less than 2 cm in greatest dimension and 5 or fewer positive nodes, none larger than 2 cm in greatest dimension (finding)
370021006N2: Metastasis with a lymph node mass >2 cm but <= 5 cm in greatest dimension, or more than 5 nodes positive, none > 5 cm; or evidence of extranodal extension of tumor
370022004N3: Metastasis with a lymph node mass > 5 cm in greatest dimension
370023009N1: Metastasis in regional lymph node or nodes
370024003N1: Pelvic or inguinal lymph node metastasis (finding)
370025002N1a: Metastasis in ipsilateral cervical lymph node(s)
370026001N1b: Metastasis in bilateral, midline, or contralateral cervical or mediastinal lymph node(s)
370027005N1a: Metastasis in single regional lymph node
370028000N1b: Metastasis in multiple regional lymph nodes
370029008M1 (IV): Distant metastasis
370030003M1 (IVB): Distant metastasis
370031004M1: Distant metastasis [includes metastasis to ipsilateral supraclavicular lymph nodes] (finding)
370032006M1: Distant metastasis, includes separate tumor nodule(s) in a different lobe (ipsilateral or contralateral)
370033001M1a: Non-regional lymph node or pulmonary metastasis
370034007M1a: non-regional lymph node metastasis
370035008M1a (III): GTT extends to the lungs with or without genital tract involvement
370036009M1a (IIIA): GTT extends to the lungs with or without genital tract involvement without risk factors
370037000M1a (IIIB): GTT extends to the lungs with or without genital tract involvement with one risk factor
370038005M1a (IIIC): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement with two risk factors (finding)
370039002M1b (IV): All other metastatic sites
370040000M1b (IVA): All other metastatic sites without risk factors
370041001M1b (IVB): All other metastatic sites with one risk factor
370042008M1b (IVC): All other metastatic sites with two risk factors
370043003M1b: Bone(s)
370044009M1b: Distant metastasis other than to non-regional lymph nodes and lungs
370045005M1c: Other site(s) (finding)
370046006T3a,b: Colon/rectum tumor invades <=5 mm beyond the border of the muscularis propria
370047002T3c,d: Colon/rectum tumor invades >5 mm beyond the border of the muscularis propria
370072002Direct invasion of adrenal (T3a)
370123006N1: Regional lymph node metastasis
372436009N1: Metastasis in perirectal lymph node or nodes
372437000N2: Metastasis to unilateral internal iliac and/or inguinal lymph node(s)
373150000pNX: Regional lymph nodes cannot be assessed (e.g., previously removed, or not removed for pathologic study) (breast)
373151001pN0: No regional lymph node metastasis histologically (i.e., none greater than 0.2 mm), no additional examination for isolated tumor cells (breast) (finding)
373156006pN1: Metastasis in 1 to 3 axillary lymph nodes, and/or in internal mammary nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast) (finding)
373157002pN1mi: Micrometastasis (greater than 0.2 mm, none greater than 2.0 mm) (breast)
373158007pN1mi(i+): Micrometastasis detected only by IHC (breast)
373159004pN1a: Metastasis in 1 to 3 axillary lymph nodes (at least one tumor deposit greater than 2.0 mm) (breast) (finding)
373160009pN1b: Metastasis in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast)
373161008pN1c: Metastasis in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast)
373162001pN2: Metastasis in 4 to 9 axillary lymph nodes, or in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast)
373163006pN2a: Metastasis in 4 to 9 axillary lymph nodes (at least one tumour deposit greater than 2.0 mm) (breast)
373164000pN2b: Metastasis in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast)
373165004pN3a: Metastasis in 10 or more axillary lymph nodes (at least one tumour deposit greater than 2.0 mm), or metastasis to infraclavicular lymph nodes (breast)
373166003pN3c: Metastasis in ipsilateral supraclavicular lymph nodes (breast)
373167007pN3b: Tumour of breast with metastasis as per AJCC 6th Edition definition (breast)
373169005pM0: No distant metastasis (breast) (finding)
373170006pMX: Distant metastasis cannot be assessed (breast)
373171005pM1: Distant metastasis (breast)
373172003pT1: Tumor 2 cm or less in greatest dimension (breast) (finding)
373173008pTX: Primary tumour cannot be assessed (breast)
373174002pT0: No evidence of primary tumour (breast)
373175001pTis: Carcinoma in situ (breast)
373176000pTis: Ductal carcinoma in situ (breast)
373177009pTis: Lobular carcinoma in situ (breast)
373178004pTis: Paget disease without invasive carcinoma (breast) (finding)
373179007pT1mic: Microinvasion 0.1 cm or less in greatest dimension (breast) (finding)
373180005pT1a: Tumor more than 0.1 cm but not more than 0.5 cm in greatest dimension (breast) (finding)
373182002pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (breast) (finding)
373183007pT1c: Tumor more than 1 cm but not more than 2 cm in greatest dimension (breast) (finding)
373184001pT3: Tumor more than 5 cm in greatest dimension (breast) (finding)
373185000pT4: Tumour of any size with direct extension to chest wall or skin (breast)
373186004pT4a: Tumour of any size with extension to chest wall, not including pectoralis muscle (breast)
373187008pT4b: Tumour of any size with oedema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast
373189006pT4c: Tumour of any size with direct extension to chest wall (not including pectoralis muscle) and oedema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast
373190002pT4d: Inflammatory carcinoma (breast)
373199001pTis: Tumour invades muscularis mucosae (colon/rectum)
373200003pT1: Tumor invades submucosa (colon/rectum) (finding)
373201004pTis: Carcinoma in situ, invasion of lamina propria (finding)
373204007pT1b: Tumor more than 0.5 cm but not more than 1 cm in greatest dimension (breast) (finding)
384612007pT4a: Tumor directly invades other organs or structures (colon/rectum) (finding)
384613002pT4b: Tumor penetrates visceral peritoneum (colon/rectum) (finding)
384748000pM1: Distant metastasis, includes separate tumor nodule(s) in a different lobe (ipsilateral or contralateral) (lung) (finding)
384749008pN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumor (lung) (finding)
384750008pN2: Metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes(s) (lung) (finding)
384751007pN3: Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s) (lung) (finding)
384753005pT1: Tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus) (lung) (finding)
384754004pT2: Tumour of lung as per AJCC 6th Edition definition (lung)
384755003pT3:Tumor directly invades any of following:chest wall,diaphragm,mediastinal pleura,parietal pericardium;or tumor in main bronchus<2 cm distal to carina(not involving it);or assoc atelectasis or obstructive pneumonitis of whole lung (finding)
384756002pT4: Tumour of lung as per AJCC 6th Edition definition (lung)
384757006pTX: Primary tumor cannot be assessed, or tumor proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging or bronchoscopy (lung) (finding)
384983005pT2: Organ confined (prostate) (finding)
384984004pT2a: Unilateral, one-half of one lobe or less (prostate) (finding)
384985003pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) (finding)
384986002pT2c: Bilateral disease (prostate) (finding)
384987006pT3: Extraprostatic extension (prostate) (finding)
384988001pT3a: Extraprostatic extension (prostate) (finding)
384989009pT3b: Seminal vesicle invasion (prostate) (finding)
384990000pT4: Invasion of bladder AND/OR rectum (prostate) (finding)
385301007pT1: Tumor 2 cm or less in greatest dimension (anal canal) (finding)
385302000pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (anal canal) (finding)
385303005pT3: Tumor more than 5 cm in greatest dimension (anal canal) (finding)
385304004pT4: Tumor of any size invades adjacent organ(s), e.g., vagina, urethra, bladder (anal canal) (finding)
385306002pN1: Metastasis in perirectal lymph node(s) (anal canal) (finding)
385307006pN2: Metastasis in unilateral internal iliac AND/OR inguinal lymph node(s) (anal canal) (finding)
385308001pN3: Metastasis in perirectal and inguinal lymph nodes AND/OR bilateral internal iliac AND/OR inguinal lymph nodes (anal canal) (finding)
385316005pT1: Tumor invades lamina propria or submucosa (stomach) (finding)
385317001pT1a: Tumor invades lamina propria (stomach) (finding)
385318006pT1b: Tumor invades submucosa (stomach) (finding)
385319003pT2: Tumor invades muscularis propria or subserosa (stomach) (finding)
385320009pT2a: Tumor invades muscularis propria (stomach) (finding)
385321008pT2b: Tumor invades subserosa (stomach) (finding)
385322001pT3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures (stomach) (finding)
385323006pT4: Tumor invades adjacent structures (stomach) (finding)
385324000pN1: Metastasis in 1 to 6 regional (perigastric) lymph nodes (stomach) (finding)
385325004pN2: Metastasis in 7 to 15 regional (perigastric) lymph nodes (stomach) (finding)
385326003pN3: Metastasis in more than 15 regional (perigastric) lymph nodes (stomach) (finding)
385358008Dukes stage finding (finding)
385360005Modified Dukes stage finding (finding)
385362002FIGO stage finding for gynaecological malignancy
385364001FIGO ovarian tumour stage finding
385366004FIGO stage finding for epithelial tumour of ovary
385368003FIGO stage finding for cervical carcinoma
385370007FIGO stage finding for vulvar carcinoma
385372004FIGO stage finding for vulvar melanoma
385374003FIGO uterine tumour stage finding
385376001FIGO stage finding for endometrial carcinoma
385378000pM category finding (finding)
385379008TNM tumour staging finding
385380006Metastasis category finding (finding)
385381005pN category finding (finding)
385382003Node category finding (finding)
385385001pT category finding (finding)
385389007Lymphoma stage finding (finding)
385392006Colon/rectum TNM finding (finding)
385415005Anal canal TNM finding (finding)
385416006Prostate TNM finding (finding)
385417002Breast TNM finding (finding)
385418007Lung TNM finding (finding)
394939004Dukes stage A (finding)
394940002Dukes stage B (finding)
394941003Dukes stage C1 (finding)
394942005Dukes stage C2 (finding)
394943000Dukes stage D (finding)
395705003pTis: Carcinoma in situ, intraepithelial (colon/rectum) (finding)
395706002pT2: Tumor invades muscularis propria (colon/rectum) (finding)
395707006pT3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues (colon/rectum) (finding)
395708001pT3a,b: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues, invades 5 mm or less beyond the border of the muscularis propria (colon/rectum) (finding)
395709009pT3c,d: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues, invades greater than 5 mm beyond the border of the muscularis propria (colon/rectum) (finding)
395710004pT4: Tumor directly invades other organs or structures and/or perforates visceral peritoneum (colon/rectum) (finding)
395711000pN1: Metastasis in 1 to 3 regional lymph nodes (colon/rectum) (finding)
395712007pN2: Metastasis in 4 or more regional lymph nodes (colon/rectum) (finding)
396082002pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney (kidney) (finding)
396083007Kidney TNM finding (finding)
396084001pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney (kidney) (finding)
396085000pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney (kidney) (finding)
396086004pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney (kidney) (finding)
396087008pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) (finding)
396088003pT3a: Tumor directly invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) (finding)
396089006pT3b: Tumor grossly extends into the renal vein or its segmental (muscle-containing) branches, or vena cava below the diaphragm (kidney) (finding)
396090002pT3c: Tumor grossly extends into vena cava above diaphragm or invades the wall of the vena cava (kidney) (finding)
396091003pT4: Tumor invades beyond Gerota's fascia (kidney) (finding)
396092005pN1: Metastasis in a single regional lymph node (kidney) (finding)
396093000pN2: Metastasis in more than one regional lymph node (kidney) (finding)
396094006Ampulla of Vater TNM finding (finding)
396095007pT1: Tumor limited to ampulla of Vater or sphincter of Oddi (ampulla of Vater) (finding)
396096008pT2: Tumor invades duodenal wall (ampulla of Vater) (finding)
396097004pT3: Tumor invades pancreas (ampulla of Vater) (finding)
396098009pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures (ampulla of Vater) (finding)
396099001Liver TNM finding (finding)
396100009pT1: Solitary tumor without vascular invasion (liver, including intrahepatic bile ducts) (finding)
396101008pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts) (finding)
396102001pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) (finding)
396103006pT4: Tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum (liver, including intrahepatic bile ducts) (finding)
396282005Uterine cervix TNM finding (finding)
396283000pT1 (I): Cervical carcinoma confined to uterus (extension to corpus should be disregarded) (TNM category and FIGO stage) (uterine cervix) (finding)
396287004pT1a (IA): Invasive carcinoma diagnosed only by microscopy. All macroscopically visible lesions (even with superficial invasion) are pT1b/IB (TNM category and FIGO stage) (uterine cervix) (finding)
396288009pT1a1 (IA1): Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread (TNM category and FIGO stage) (uterine cervix) (finding)
396289001pT1a2 (IA2): Measured stromal invasion more than 3.0 mm and not more than 5.0 mm in depth and 7.0 mm or less horizontal spread (TNM category and FIGO stage) (uterine cervix) (finding)
396290005pT1b (IB): Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 (TNM category and FIGO stage) (uterine cervix) (finding)
396291009pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension (TNM category and FIGO stage) (uterine cervix) (finding)
396292002pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension (TNM category and FIGO stage) (uterine cervix) (finding)
396294001pT2 (II): Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina (TNM category and FIGO stage) (uterine cervix) (finding)
396297008pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) (finding)
396298003pT2b (IIB): Tumor with parametrial invasion (TNM category and FIGO stage) (uterine cervix) (finding)
396299006pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) (finding)
396300003pT3a (IIIA): Tumor involves lower third of vagina, no extension to pelvic wall (TNM category and FIGO stage) (uterine cervix) (finding)
396301004pT3b (IIIB): Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) (finding)
396302006pT4 (IVA): Tumor invades mucosa of bladder or rectum and/or extends beyond true pelvis (bullous edema is not sufficient evidence to classify a tumor as pT4) (TNM category and FIGO stage) (uterine cervix) (finding)
396303001pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (corpus uteri) (finding)
396311006Corpus uteri TNM finding (finding)
396312004pT1 (I): Tumor confined to corpus uteri (TNM category and FIGO stage) (corpus uteri) (finding)
396313009pT1a (IA): Tumor limited to endometrium (TNM category and FIGO stage) (corpus uteri) (finding)
396314003pT1b (IB): Tumor invades less than one-half of the myometrium (TNM category and FIGO stage) (corpus uteri) (finding)
396315002pT1c (IC): Tumor invades one-half or more of the myometrium (TNM category and FIGO stage) (corpus uteri) (finding)
396316001pT2 (II): Tumor invades cervix but does not extend beyond uterus (TNM category and FIGO stage) (corpus uteri) (finding)
396317005pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) (finding)
396318000pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) (finding)
396319008pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) (finding)
396320002pT3a (IIIA): Tumor involves serosa, AND/OR adnexa (direct extension or metastasis) AND/OR cancer cells in ascites or peritoneal washings (TNM category and FIGO stage) (corpus uteri) (finding)
396321003pT3b (IIIB): Involvement of vagina (direct extension or metastasis), rectal or bladder wall (without mucosal involvement), or pelvic wall(s) (frozen pelvis) (TNM category and FIGO stage) (corpus uteri) (finding)
396322005pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa (TNM category and FIGO stage) (corpus uteri) (finding)
396323000pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (corpus uteri) (finding)
396368008Skin melanoma TNM finding (finding)
396369000pTis: Melanoma in situ (melanoma of the skin) (finding)
396370004pT1: Melanoma 1.0 mm or less in thickness, with or without ulceration (melanoma of the skin) (finding)
396371000pT1a: Melanoma 1.0 mm or less in thickness and level II or III, no ulceration (melanoma of the skin) (finding)
396372007pT1b: Melanoma 1.0 mm or less in thickness and level IV or V or with ulceration (melanoma of the skin) (finding)
396373002pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) (finding)
396374008pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) (finding)
396375009pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) (finding)
396376005pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) (finding)
396377001pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration (melanoma of the skin) (finding)
396378006pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration (melanoma of the skin) (finding)
396379003pT4: Melanoma greater than 4.0 mm in thickness, with or without ulceration (melanoma of the skin) (finding)
396380000pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration (melanoma of the skin) (finding)
396381001pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration (melanoma of the skin) (finding)
396382008pN1: Metastasis in one regional lymph node (melanoma of the skin) (finding)
396383003pN1a: Clinically occult (microscopic) metastasis (melanoma of the skin) (finding)
396384009pN1b: Clinically apparent (macroscopic) metastasis (melanoma of the skin) (finding)
396385005pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis (melanoma of the skin) (finding)
396386006pN2a: Clinically occult (microscopic) metastasis (melanoma of the skin) (finding)
396387002pN2b: Clinically apparent (macroscopic) metastasis (melanoma of the skin) (finding)
396388007pN2c: Satellite or in-transit metastasis without nodal metastasis (melanoma of the skin) (finding)
396389004pN3: Metastasis in four or more regional nodes, or matted metastatic nodes, or in-transit metastasis or satellite(s) with metastasis in regional node(s) (melanoma of the skin) (finding)
396390008pM1a: Metastasis to skin, subcutaneous tissues, or distant lymph nodes (melanoma of the skin) (finding)
396391007pM1b: Metastasis to lung (melanoma of the skin) (finding)
396392000pM1c: Metastasis to visceral site other than lung or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (LDH) (melanoma of the skin)
396492004Carcinoma of skin (excluding eyelid, vulva, penis, and melanomas) TNM finding (finding)
396493009pT1: Tumor 2 cm or less in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396494003pT1a: Tumor 2 cm or less in greatest dimension, limited to dermis or 2 mm or less in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396495002pT1b: Tumor 2 cm or less in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396496001pT1c: Tumor 2 cm or less in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396497005pT2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396498000pT2a: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396499008pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396500004pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396501000pT3: Tumor more than 5 cm in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396502007pT3a: Tumor more than 5 cm in greatest dimension, limited to dermis or not more than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396503002pT3b: Tumor more than 5 cm in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396504008pT3c: Tumor more than 5 cm in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396506005pT4: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396507001pT4b: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) greater than 6mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396508006pT4a: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) not more than 6mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)
396532004Stage I: Tumor confined to gland, 5 cm or less (adrenal cortical carcinoma) (finding)
396533009Stage II: Tumor confined to gland, greater than 5 cm (adrenal cortical carcinoma) (finding)
396534003Stage III: Extraglandular extension of tumor without other organ involvement (adrenal cortical carcinoma) (finding)
396535002Stage IV: Distant metastasis or extension into other organs (adrenal cortical carcinoma) (finding)
396566008Oropharynx TNM finding (finding)
396567004pT1: Tumor 2 cm or less in greatest dimension (oropharynx) (finding)
396568009Upper aerodigestive tract TNM finding (finding)
396569001pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (oropharynx) (finding)
396570000pT3: Tumor more than 4 cm in greatest dimension (oropharynx) (finding)
396571001pT4a: Tumor invades the larynx, deep/extrinsic muscle of tongue, medial pterygoid muscle, hard palate, or mandible (oropharynx) (finding)
396572008pT4b: Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery (oropharynx) (finding)
396573003Lip and oral cavity TNM finding (finding)
396574009pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity) (finding)
396575005pT1: Tumor 2 cm or less in greatest dimension (lip and oral cavity) (finding)
396576006pT1: Tumor 2 cm or less in greatest dimension (finding)
396577002pT3: Tumor more than 4 cm in greatest dimension (lip and oral cavity) (finding)
396578007pT4a: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, i.e., chin or nose (lip) (finding)
396579004pT4a: Tumor invades through cortical bone, into deep (extrinsic) muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), maxillary sinus, or skin of face (oral cavity) (finding)
396580001pT4b: Tumor involves masticator space, pterygoid plates, or skull base and/or encases internal carotid artery (lip and oral cavity) (finding)
396581002Hypopharyngeal TNM finding (finding)
396582009Nasopharynx TNM finding (finding)
396583004pT1: Tumor confined to the nasopharynx (nasopharynx) (finding)
396584005pT2a: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx) (finding)
396585006pT2: Tumor extends to the soft tissues (nasopharynx) (finding)
396586007pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) (finding)
396587003pT3: Tumor involves bony structures and/or paranasal sinuses (nasopharynx) (finding)
396588008pT4: Tumor with intracranial extension, and/or involvement of cranial nerves, infratemporal fossa, hypopharynx, orbit, or masticator space (nasopharynx) (finding)
396589000pT1: Tumor limited to one subsite of hypopharynx and 2 cm or less in greatest dimension (hypopharynx) (finding)
396590009pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) (finding)
396591008pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilarynx (hypopharynx) (finding)
396592001pT4a: Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, esophagus or central compartment of soft tissue (hypopharynx) (finding)
396593006pT4b: Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures (hypopharynx) (finding)
396594000Supraglottis TNM finding (finding)
396595004pT1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility (larynx, supraglottis) (finding)
396596003pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx (finding)
396597007pT3: Tumor limited to the larynx with vocal cord fixation and/or invades any of the following: postcrocoid area, pre-epiglottic tissues, paraglottic space, and/or minor thyroid cartilage erosion (e.g., inner cortex) (larynx, supraglottis) (finding)
396598002pT4a: Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (larynx, supraglottis) (finding)
396599005pT4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (larynx, supraglottis) (finding)
396600008Glottis TNM finding (finding)
396601007pT1: Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) (finding)
396602000pT1a: Tumor limited to one vocal cord (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) (finding)
396603005pT1b: Tumor involves both vocal cords (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) (finding)
396604004pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) (finding)
396605003pT3: Tumor limited to the larynx with vocal cord fixation, and/or invades the paraglottic space, and/or minor thyroid cartilage erosion (larynx, glottis) (finding)
396606002pT4a: Tumor invades through thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep intrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (larynx, glottis) (finding)
396607006pT4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (larynx, glottis) (finding)
396608001Subglottis TNM finding (finding)
396609009pT1: Tumor limited to the subglottis (larynx, subglottis) (finding)
396610004pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) (finding)
396611000pT3: Tumor limited to larynx with vocal cord fixation (larynx, subglottis) (finding)
396612007pT4a: Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (larynx, subglottis) (finding)
396613002pT4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (larynx, subglottis) (finding)
396614008Maxillary sinus TNM finding (finding)
396615009pT1: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone (maxillary sinus) (finding)
396616005pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) (finding)
396617001pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus) (finding)
396618006pT4a: Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses (maxillary sinus) (finding)
396619003pT4b: Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus (maxillary sinus) (finding)
396621008Nasal cavity and ethmoid sinus TNM finding (finding)
396622001pT1: Tumor restricted to any one subsite, with or without bony invasion (nasal cavity and ethmoid sinus) (finding)
396623006pT2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus) (finding)
396624000pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus) (finding)
396625004pT4a: Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses (nasal cavity and ethmoid sinus) (finding)
396626003pT4b: Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus (nasal cavity and ethmoid sinus) (finding)
396632008pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension (upper aerodigestive tract) (finding)
396633003pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension (upper aerodigestive tract) (finding)
396634009pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract) (finding)
396635005pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract) (finding)
396636006pN3: Metastasis in a lymph node, more than 6 cm in greatest dimension (upper aerodigestive tract) (finding)
396637002pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa (nasopharynx) (finding)
396638007pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa (nasopharynx) (finding)
396639004pN3: Metastasis in a lymph node(s), more than 6 cm in dimension, and/or to supraclavicular fossa (nasopharynx) (finding)
396640002pN3a: Metastasis in a lymph node(s), more than 6 cm in dimension (nasopharynx) (finding)
396641003pN3b: Metastasis in lymph node(s) residing wholly or in part in the supraclavicular fossa (nasopharynx) (finding)
396648009Major salivary gland TNM finding (finding)
396650001pT1: Tumor 2 cm or less in greatest dimension without extraparenchymal extension (major salivary glands)
396651002pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands) (finding)
396653004pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension (major salivary glands) (finding)
396657003pT4a: Tumor invades skin, mandible, ear canal, and/or facial nerve (major salivary glands) (finding)
396658008pT4b: Tumor invades skull base and/or pterygoid plates and/or encases carotid artery (major salivary glands) (finding)
396666004Urinary bladder, ureter, or renal pelvis TNM finding (finding)
396667008pTa: Non-invasive papillary carcinoma (urinary bladder, ureter, renal pelvis) (finding)
396668003pTis: Flat carcinoma in situ (urinary bladder, ureter, renal pelvis) (finding)
396669006pT1: Tumor invades subepithelial connective tissue (urinary bladder, ureter, renal pelvis) (finding)
396670007pT2: Tumor invades muscularis propria (urinary bladder, ureter, renal pelvis) (finding)
396671006pT2a: Tumor invades superficial muscle (inner half) (urinary bladder) (finding)
396672004pT2b: Tumor invades deep muscle (outer half) (urinary bladder) (finding)
396673009pT3: Tumor invades perivesical tissue (urinary bladder) (finding)
396674003pT3a: Tumor invades perivesical tissue microscopically (urinary bladder) (finding)
396675002pT3b: Tumor invades perivesical tissue macroscopically (extravesical mass) (urinary bladder) (finding)
396676001pT4: Tumor invades any of the following: prostate, uterus, vagina, pelvic wall, abdominal wall (urinary bladder) (finding)
396677005pT4a: Tumor invades prostate or uterus or vagina (urinary bladder) (finding)
396678000pT4b: Tumor invades pelvic wall or abdominal wall (urinary bladder) (finding)
396679008pN1: Metastasis in a single lymph node, 2 cm or less in greatest dimension (urinary bladder, ureter, renal pelvis) (finding)
396680006pN2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) (finding)
396681005pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis) (finding)
396682003pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat (renal pelvis and ureter) (finding)
396683008pT3: Tumour invades beyond muscularis into periureteric fat (ureter)
396684002pT2: Tumor invades muscularis (renal pelvis and ureter) (finding)
396726006Testis TNM finding (finding)
396727002pTis: Intratubular germ cell neoplasia (carcinoma in situ) (testis) (finding)
396728007pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis (testis) (finding)
396729004pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis (testis) (finding)
396730009pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion (testis) (finding)
396731008pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion (testis) (finding)
396732001pN1: Metastasis with a lymph node mass 2 cm or less in greatest dimension and less than or equal to 5 nodes positive, none more than 2 cm in greatest dimension (testis) (finding)
396733006pN2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or more than 5 nodes positive, none more than 5 cm; or evidence of extranodal extension of tumor (testis) (finding)
396734000pN3: Metastasis with a lymph node mass more than 5 cm in greatest dimension (testis) (finding)
396735004pM1a: Non-regional nodal or pulmonary metastasis (testis) (finding)
396736003pM1b: Distant metastasis other than to non-regional lymph nodes and lungs (testis) (finding)
396797009Exocrine pancreas TNM finding (finding)
396798004pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension (exocrine pancreas) (finding)
396799007pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas) (finding)
396800006pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas) (finding)
396801005pN1a: Metastasis in single regional lymph node (exocrine pancreas) (finding)
396802003pN1b: Metastasis in multiple regional lymph node(s) (exocrine pancreas) (finding)
396803008pT4: Tumor involves the celiac axis or the superior mesenteric artery (exocrine pancreas) (finding)
396907008Thymic epithelial neoplasm stage finding (finding)
396908003Stage I: Grossly and microscopically encapsulated (thymus gland) (finding)
396909006Stage IIa: Microscopic transcapsular invasion (thymus gland) (finding)
396910001Stage IIb: Macroscopic capsular invasion into thymic or surrounding fat, or grossly adherent to, but not breaking through, mediastinal pleura or pericardium (thymus gland) (finding)
396911002Stage III: Macroscopic invasion of neighboring organs (thymus gland) (finding)
396912009Stage IVa: Pleural or pericardial dissemination (thymus gland) (finding)
396913004Stage IVb: Hematogenous or lymphatic dissemination (thymus gland) (finding)
396960007Retinoblastoma TNM finding (finding)
396961006pT1: Tumor confined to the retina, vitreous, or subretinal space. No optic nerve or choroidal invasion (retinoblastoma) (finding)
396962004pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) (finding)
396963009pT2a: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma) (finding)
396964003pT2b: Tumor invades choroid focally (retinoblastoma) (finding)
396965002pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) (finding)
396966001pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma) (finding)
396967005pT3a: Tumor invades optic nerve through the level of the lamina cribrosa but not to the line of resection (retinoblastoma) (finding)
396968000pT3b: Tumor massively invades the choroid (retinoblastoma) (finding)
396969008pT3c: Tumor invades the optic nerve through the level of the lamina cribrosa but not to the line of resection and massively invades the choroid (retinoblastoma) (finding)
396970009pT4: Extraocular tumour extension which includes sites as per AJCC 6th Edition definition (retinoblastoma)
396971008pM1a: Distant metastasis to bone marrow (retinoblastoma) (finding)
396972001pM1b: Distant metastasis to sites other than bone marrow (retinoblastoma) (finding)
397025005Stomach TNM finding (finding)
397026006pT1: Tumor invades lamina propria or submucosa (esophagus) (finding)
397027002Esophagus TNM finding (finding)
397029004pT1a: Tumor invades lamina propria (esophagus) (finding)
397030009pT1b: Tumor invades submucosa (esophagus) (finding)
397031008pT2: Tumor invades muscularis propria (esophagus) (finding)
397032001pT3: Tumor invades adventitia (esophagus) (finding)
397033006pT4: Tumor invades adjacent structures (esophagus) (finding)
397036003pN1a: Metastasis in 1 to 3 regional lymph nodes (esophagus) (finding)
397037007pN1b: Metastasis in 4 to 7 regional lymph nodes (esophagus) (finding)
397038002pN1c: Metastasis in more than 7 regional lymph nodes (esophagus) (finding)
397039005pM1a: Metastasis in celiac lymph nodes (lower thoracic esophagus) (finding)
397040007pM1a: Distant metastasis not applicable (midthoracic esophagus) (finding)
397041006pM1a: Metastasis in cervical nodes (upper thoracic esophagus) (finding)
397042004pM1b: Distant metastasis to site other than celiac lymph nodes (lower thoracic esophagus) (finding)
397043009pM1b: Nonregional lymph nodes and/or other distant metastasis (midthoracic esophagus) (finding)
397044003pM1b: Distant metastasis to site other than cervical nodes (upper thoracic esophagus) (finding)
397058001Small intestine TNM finding (finding)
397059009pT1: Tumor invades lamina propria or submucosa (small intestine) (finding)
397088005pT2: Tumor invades muscularis propria (small intestine) (finding)
397089002pT3: Tumor invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less (small intestine) (finding)
397090006pT4: Tumor perforates the visceral peritoneum or directly invades other organs or structures (small intestine) (finding)
397092003Gallbladder TNM finding (finding)
397093008pT1: Tumor invades lamina propria or muscle layer (gallbladder) (finding)
397094002pT1a: Tumor invades lamina propria (gallbladder) (finding)
397095001pT1b: Tumor invades muscle layer (gallbladder) (finding)
397096000pT2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder) (finding)
397097009pT3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts (gallbladder) (finding)
397098004pT4: Tumor invades main portal vein or hepatic artery or invades two or more extrahepatic organs or structures (gallbladder) (finding)
397101000Vagina TNM finding (finding)
397102007pT1 (I): Tumor confined to vagina (TNM category and FIGO stage) (vagina) (finding)
397103002pT2 (II): Tumor invades paravaginal tissues but not to pelvic wall (TNM category and FIGO stage) (vagina) (finding)
397104008pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina) (finding)
397105009pT4 (IVA): Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4) (TNM category and FIGO stage) (vagina) (finding)
397106005pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (vagina) (finding)
397107001pN1: Pelvic or inguinal lymph node metastasis (vagina) (finding)
397119009Vulva TNM finding (finding)
397120003pT1 (I): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension (TNM category and FIGO stage) (vulva) (finding)
397121004pT1a (IA): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion no greater than 1 mm (TNM category and FIGO stage) (vulva) (finding)
397122006pT1b (IB): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion greater than 1 mm (TNM category and FIGO stage) (vulva) (finding)
397123001pT2 (II): Tumor confined to the vulva or vulva and perineum, more than 2 cm in greatest dimension (TNM category and FIGO stage) (vulva) (finding)
397124007pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) (finding)
397125008pT4 (IVA): Tumor invades any of the following: upper urethra, bladder mucosa, rectal mucosa, or is fixed to the pubic bone (TNM category and FIGO stage) (vulva) (finding)
397126009pN1: Unilateral regional lymph node metastasis (vulva) (finding)
397127000pN2: Bilateral regional lymph node metastasis (vulva) (finding)
397146004Extrahepatic bile ducts TNM finding (finding)
397147008pT1: Tumor confined to the bile duct histologically (extrahepatic bile ducts) (finding)
397148003pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts) (finding)
397149006pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts) (finding)
397150006pT4: Tumor invades any of the following: main portal vein or its branches bilaterally, common hepatic artery, or other adjacent structures, such as the colon, stomach, duodenum, or abdominal wall (extrahepatic bile ducts) (finding)
397213002pM1a: Distant metastasis to non-regional lymph node(s) (prostate) (finding)
397214008pM1b: Distant metastasis to bone(s) (prostate) (finding)
397215009pM1c: Distant metastasis site other than bone or non-regional lymph node(s) (prostate) (finding)
397316007Ovary TNM finding (finding)
397317003pM1 (IV): Distant metastasis (TNM category and FIGO stage) (ovary) (finding)
397360007pT3a (IIIA): Tumor involves serosa, AND/OR adnexa (direct extension or metastasis) (TNM category and FIGO stage) (corpus uteri) (finding)
397367005pN1 (III): Pelvic or inguinal lymph node metastasis (pT1-pT3) (TNM category and FIGO stage) (vagina) (finding)
397368000pN1 (IVA): Pelvic or inguinal lymph node metastasis (pT4) (TNM category and FIGO stage) (vagina) (finding)
397369008pN1 (IVB): Pelvic or inguinal lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vagina) (finding)
397370009pN1 (III): Unilateral regional lymph node metastasis (pT1-pT3) (TNM category and FIGO stage) (vulva) (finding)
397371008pN1 (IVA): Unilateral regional lymph node metastasis (pT4) (TNM category and FIGO stage) (vulva) (finding)
397372001pN1 (IVB): Unilateral regional lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vulva) (finding)
397373006pN2 (IVA): Bilateral regional lymph node metastasis (pT1-pT4) (TNM category and FIGO stage) (vulva) (finding)
397374000pN2 (IVB): Bilateral regional lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vulva) (finding)
397375004pM1 (IVB): Distant metastasis (including pelvic lymph node metastasis) (TNM category and FIGO stage) (vulva) (finding)
397385003Thoracic mesothelioma TNM finding (finding)
397386002pT1: Tumor involves ipsilateral parietal pleura, with or without focal involvement of visceral pleura (thoracic mesothelioma) (finding)
397387006pT1a: Tumor involves ipsilateral parietal (mediastinal, diaphragmatic) pleura. No involvement of the visceral pleura (thoracic mesothelioma) (finding)
397388001pT1b: Tumor involves ipsilateral parietal (mediastinal, diaphragmatic) pleura, with focal involvement of the visceral pleura (thoracic mesothelioma) (finding)
397389009pT2: Tumor involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumor (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma) (finding)
397390000pN1: Metastasis in the ipsilateral bronchopulmonary and/or hilar lymph node(s) (thoracic mesothelioma) (finding)
397391001pN2: Metastasis in the subcarinal lymph node(s) and/or the ipsilateral internal mammary or mediastinal lymph node(s) (thoracic mesothelioma) (finding)
397392008pN3: Metastasis in the contralateral mediastinal, internal mammary, or hilar lymph node(s), and/or the ipsilateral or contralateral supraclavicular or scalene lymph node(s) (thoracic mesothelioma) (finding)
397393003pT3: Tumour involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma)
397465003pT4: Tumour involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma)
397470005Gestational trophoblast TNM finding (finding)
397471009pT1 (I): Tumor confined to uterus (TNM category and FIGO stage) (gestational trophoblast) (finding)
397472002pT2 (II): Tumor extends outside of uterus but limited to genital structures (ovary, tube, vagina, broad ligaments) (TNM category and FIGO stage) (gestational trophoblast) (finding)
397473007pM1a (III): Tumor extends to the lungs with or without genital tract involvement (TNM category and FIGO stage) (gestational trophoblast) (finding)
397474001pM1b (IV): Distant metastasis other than lung (TNM category and FIGO stage) (gestational trophoblast) (finding)
397489005pT1 (I): Tumor limited to ovaries (one or both) (TNM category and FIGO stage) (ovary) (finding)
397490001pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding)
397491002pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding)
397492009pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding)
397493004pT2 (II): Tumor involves one or both ovaries with pelvic extension AND/OR implants (TNM category and FIGO stage) (ovary) (finding)
397494005pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding)
397495006pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding)
397496007pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding)
397497003pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) (finding)
397498008pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) (TNM category and FIGO stage) (ovary) (finding)
397499000pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension (TNM category and FIGO stage) (ovary) (finding)
397500009pT3c AND/OR N1 (IIIC): Peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension AND/OR regional lymph node metastasis (TNM category and FIGO stage) (ovary) (finding)
397501008Any T/any N and M1 (IV): Growth involving one or both ovaries with distant metastasis. (TNM category and FIGO stage) (ovary) (finding)
399378007pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) (finding)
399393006pT3: Tumor more than 4 cm in greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues) (thyroid) (finding)
399397007pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) (finding)
399400003pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands) (finding)
399401004Insufficient tissue to assess highest pT category (finding)
399404007pT3b (IIIB): Tumor involves one or both fallopian tubes, with macroscopic peritoneal metastasis outside the pelvis 2 cm or less in greatest dimension (TNM category and FIGO stage) (fallopian tube) (finding)
399410007pT3c (IIIC): Tumor involves one or both fallopian tubes, with peritoneal metastasis outside the pelvis more than 2 cm in diameter (TNM category and FIGO stage) (fallopian tube) (finding)
399413009Thyroid TNM finding (finding)
399425007pT1a (IA): Tumor limited to one fallopian tube, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube) (finding)
399439007pT1: Tumor 2 cm or less in greatest dimension limited to the thyroid (thyroid) (finding)
399446003pT4b: Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels (thyroid) (finding)
399448002pT1: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) (ciliary body and choroid) (uveal melanoma) (finding)
399452002pM1b: Distant metastasis (esophagus) (finding)
399453007No pT1 category, insufficient tissue (prostate) (finding)
399454001pT1c (IC): Tumor limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) (finding)
399461002pT1b: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)
399474008pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) (finding)
399478006pT1 (I): Tumor limited to the fallopian tube(s) (TNM category and FIGO stage) (fallopian tube) (finding)
399481001pN1a: Metastasis to level VI (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes) (thyroid) (finding)
399493005pT1c: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)
399501001pT1: Tumor limited to the iris (iris) (uveal melanoma) (finding)
399508007pT4b: Extrathyroidal anaplastic carcinoma - surgically unresectable (anaplastic carcinoma) (thyroid) (finding)
399511008pT1b: Tumor limited to the iris (more than 3 clock hours in size) (iris) (uveal melanoma) (finding)
399516003pT1a: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)
399517007Tumor stage cannot be determined (finding)
399518002pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid) (finding)
399519005pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)
399543008pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)
399553009pN3: Metastasis in a lymph node, more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) (finding)
399557005pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma) (finding)
399575006pT4a: Intrathyroidal anaplastic carcinoma - surgically resectable (anaplastic carcinoma) (thyroid) (finding)
399594001pM1a: Distant metastasis (esophagus) (finding)
399597008pT1a: Tumor limited to the iris (not more than 3 clock hours in size) (iris) (uveal melanoma) (finding)
399602001pT1c: Tumor limited to the iris with melanomalytic glaucoma (iris) (uveal melanoma) (finding)
399605004FIGO stage finding for fallopian tube tumour
399610000pT3: Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) without extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)
399615005pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) (finding)
399616006pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)
399621009pT3a (IIIA): Tumor involves one or both fallopian tubes, with microscopic peritoneal metastasis outside the pelvis (TNM category and FIGO stage) (fallopian tube) (finding)
399623007pT4a: Tumor of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve (thyroid) (finding)
399630001pT category not identified (finding)
399636007pT3c and/or N1 (IIIC): Tumor involves one or both fallopian tubes, with peritoneal metastasis outside the pelvis more than 2 cm in diameter AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) (finding)
399641004pT2 (II): Tumor involves one or both fallopian tubes with pelvic extension (TNM category and FIGO stage) (fallopian tube) (finding)
399674004pT3a: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension and melanomalytic glaucoma (iris) (uveal melanoma) (finding)
399678001pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) (finding)
399679009pT4: Tumor with extraocular extension (iris) (uveal melanoma) (finding)
399688000Fallopian tube TNM finding (finding)
399690004pT2b (IIB): Tumor involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube) (finding)
399696005pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) (finding)
399697001pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) (finding)
399704006pN1b: Metastasis to unilateral, bilateral, or contralateral cervical or superior mediastinal lymph nodes (thyroid) (finding)
399705007Uveal melanoma TNM finding (finding)
399729000pT4: Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) with extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)
399736004pT1b (IB): Tumor limited to both tubes, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube) (finding)
399749009Any T/Any N and M1 (IV): Distant metastasis including presence of malignant cells in pleural fluid or parenchymal hepatic metastasis (TNM category and FIGO stage) (fallopian tube) (finding)
404180008pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis) (finding)
404181007pM1 (IV): Distant metastasis (TNM category and FIGO stage) (fallopian tube) (finding)
404182000pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (uterine cervix) (finding)
405917009Intergroup rhabdomyosarcoma study post-surgical clinical group finding (finding)
405918004Intergroup rhabdomyosarcoma study post-surgical clinical group not applicable (finding)
405919007Intergroup rhabdomyosarcoma study post-surgical clinical group cannot be assessed (finding)
405957007Intergroup rhabdomyosarcoma study post-surgical clinical group IA: localized tumor, confined to site of origin, completely resected (finding)
405958002Intergroup rhabdomyosarcoma study post-surgical clinical group IB: localized tumor, infiltrating beyond site of origin, completely resected (finding)
405959005Intergroup rhabdomyosarcoma study post-surgical clinical group IIA: localized tumor, gross total resection, but with microscopic residual disease (finding)
405960000Intergroup rhabdomyosarcoma study post-surgical clinical group IIB: Locally extensive tumor (spread to regional lymph nodes), completely resected (finding)
405961001Intergroup rhabdomyosarcoma study post-surgical clinical group IIC: Locally extensive tumor (spread to regional lymph nodes), gross total resection, but microscopic residual disease (finding)
405962008Intergroup rhabdomyosarcoma study post-surgical clinical group IIIA: Localized or locally extensive tumor, gross residual disease after biopsy only (finding)
405963003Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localized or locally extensive tumor, gross residual disease after major resection (greater than 50% debulking) (finding)
405964009Intergroup rhabdomyosarcoma study post-surgical clinical group IV: Any size primary tumor, with or without regional lymph node involvement, with distant metastases, without respect to surgical approach to primary tumor (finding)
405992004pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (ovary) (finding)
406001009pT4b: Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases internal carotid artery (oropharynx) (finding)
406088001pN0(i-): No regional lymph node metastasis histologically, negative morphologic findings for isolated tumor cells (breast) (finding)
406089009pN0(i+): No regional lymph node metastasis histologically, positive morphologic findings for isolated tumor cells, no cluster greater than 0.2 mm (breast) (finding)
406090000pN0(mol-): No regional lymph node metastasis histologically, negative nonmorphologic (molecular) findings for isolated tumor cells (breast) (finding)
406091001pN0(mol+): No regional lymph node metastasis histologically, positive nonmorphologic (molecular) findings for isolated tumor cells (breast) (finding)
406092008pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) (finding)
409721000International neuroblastoma staging system stage finding (finding)
409722007International neuroblastoma staging system stage 1 (finding)
409723002International neuroblastoma staging system stage 2A (finding)
409724008International neuroblastoma staging system stage 2B (finding)
409725009International neuroblastoma staging system stage 3 (finding)
409726005International neuroblastoma staging system stage 4 (finding)
409727001International neuroblastoma staging system stage 4S (finding)
409747009pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)
409748004pT1: Tumor 5 cm or less in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)
409749007pT1b: Tumor 5 cm or less in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)
409750007pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)
409751006pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)
409752004pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)
409753009pT1: Tumor 8 cm or less in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)
409754003pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)
409755002pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)
409756001Primitive neuroectodermal tumor/Ewing's sarcoma TNM finding (finding)
409758000pM1a: Distant metastasis to lung (primitive neuroectodermal tumor/Ewing's sarcoma) (finding)
409759008pM1b: Distant metastasis to site other than lung (primitive neuroectodermal tumor/Ewing's sarcoma) (finding)
422375001Carcinoma of colon, stage III (finding)
422399001Infiltrating ductal carcinoma of breast, stage 1 (finding)
422479008Infiltrating ductal carcinoma of breast, stage 2 (finding)
422581008Carcinoma of colon, stage II (finding)
422679002Seminoma of testis, stage 3 (finding)
422807001pT4: Tumor directly invades other organs or structures and/or perforates visceral peritoneum (appendix) (finding)
422901001pTis: Carcinoma in situ, intraepithelial (appendix) (finding)
422985007Carcinoma of colon, stage IV (finding)
423003009pT3: Tumor invades through the muscularis propria into the subserosa or into mesoappendix (appendix) (finding)
423055005pTis: Carcinoma in situ, invasion of lamina propria (appendix) (finding)
423114009Infiltrating ductal carcinoma of breast, stage 3 (finding)
423274005Carcinoma of ovary, stage 4 (finding)
423480004Carcinoma of ovary, stage 3 (finding)
423645007Seminoma of testis, stage 2 (finding)
423697000Seminoma of testis, stage 4 (finding)
423816008Seminoma of testis, stage 1 (finding)
424078005Adenocarcinoma of lung, stage I (finding)
424229006Infiltrating ductal carcinoma of breast, stage 4 (finding)
424454009Adenocarcinoma of lung, stage III (finding)
424486004Carcinoma of ovary, stage 2 (finding)
424600001Carcinoma of ovary, stage 1 (finding)
424632001Adenocarcinoma of lung, stage II (finding)
424842001pT1: Tumor invades submucosa (appendix) (finding)
424993006Adenocarcinoma of lung, stage IV (finding)
425008003pT2: Tumor invades muscularis propria (appendix) (finding)
425037004Low grade lymphoma, stage 1 (finding)
425213009Carcinoma of colon, stage I (finding)
425566006pT1b: Tumor 5 cm or less in greatest dimension, deep tumor (soft tissue) (finding)
426288003pM1b: Distant metastasis to site other than lung (bone) (finding)
426554005pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue) (finding)
426561009Bone TNM finding (finding)
426613005pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (soft tissue) (finding)
426616002pT2: Tumor more than 8 cm in greatest dimension (bone) (finding)
426897009pT1: Tumor 8 cm or less in greatest dimension (bone) (finding)
426917009pM1a: Distant metastasis to lung (bone) (finding)
427209003pT3: Discontinuous tumors in the primary bone site (bone) (finding)
427495001pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor (soft tissue) (finding)
427535001Soft tissue TNM finding (finding)
443335006pN0(i-) category (finding)
443357004pT1a category (finding)
443452006pN2b category (finding)
443479005pT3d category (finding)
443486002pN0(i+) category (finding)
443505003pT4d category (finding)
443506002pT1b category (finding)
443599002pN1b category (finding)
443600004pT1mic category (finding)
443604008pT4a category (finding)
443606005pT3a category (finding)
443642002pT1c category (finding)
443674009pT3c category (finding)
443716008pN1a category (finding)
443721006pT4c category (finding)
443736009pT4b category (finding)
443743003pN1c category (finding)
443784000pT3c,d category (finding)
443812002pT2a category (finding)
443815000pT3a,b category (finding)
443817008pT3b category (finding)
443823003pN3c category (finding)
443824009pN1mi category (finding)
443839005pM1c category (finding)
443840007pM1b category (finding)
443841006pM1a category (finding)
443866005pN3a category (finding)
443867001pN2a category (finding)
443875007pN0(mol+) category (finding)
443893008pN2c category (finding)
443896000pT2b category (finding)
443956003pT2c category (finding)
443962008pN3b category (finding)
443963003pN0(mol-) category (finding)
444417007pT1b1 category (finding)
444432000pT1a1 category (finding)
444439009pT1a2 category (finding)
444440006pT1b2 category (finding)
445110009T4d: Inflammatory carcinoma of breast with involvement of skin and chest wall by carcinoma (finding)
708327004FIGO CC stage IA1
708331005FIGO CC stage IA2
708340009FIGO CC stage IB1
708368008FIGO CC stage IB2
708381001FIGO CC stage IIA1
708383003FIGO CC stage IIA2
708387002FIGO CC stage IIB
708393005FIGO CC stage IIIA
708395003FIGO CC stage IIIB
708400002FIGO CC stage IVA
708404006FIGO CC stage IVB
708415001FIGO EC stage IIIB
708432002FIGO EC stage IIIC1
708435000FIGO EC stage IIIC2
708443005FIGO EC stage IVA
708446002FIGO EC stage IVB
708456003Epithelial ovarian tumour, FIGO stage IIIA
708458002Epithelial ovarian tumour, FIGO stage IIIB
708460000Epithelial ovarian tumour, FIGO stage IIIC (finding)
708461001Epithelial ovarian tumour, FIGO stage IVA (finding)
708464009Epithelial ovarian tumour, FIGO stage IVB
708467002FIGO VC stage IA
708470003FIGO VC stage IB
708473001FIGO VC stage IIIA
708476009FIGO VC stage IIIB
708480004FIGO VC stage IVA
708486005FIGO VC stage IVB
708533009International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IIIA (finding)
718465002Clinical stage 0 (finding)

 

See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

LevelA few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance)
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code